Hiroko Mataki

951 total citations
16 papers, 779 citations indexed

About

Hiroko Mataki is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Hiroko Mataki has authored 16 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Hiroko Mataki's work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Hiroko Mataki is often cited by papers focused on MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Hiroko Mataki collaborates with scholars based in Japan and United States. Hiroko Mataki's co-authors include Naohiko Seki, Keiko Mizuno, Hiromasa Inoue, Yusuke Goto, Tomohiro Kumamoto, Kazuto Kamikawaji, Masayuki Nakagawa, Hideki Enokida, Rika Nishikawa and Takeshi Chiyomaru and has published in prestigious journals such as FEBS Letters, British Journal of Cancer and Oncotarget.

In The Last Decade

Hiroko Mataki

16 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Mataki Japan 14 594 545 94 70 50 16 779
Yu Qi China 17 693 1.2× 629 1.2× 102 1.1× 82 1.2× 39 0.8× 34 889
Mohammed Abba Germany 17 545 0.9× 450 0.8× 73 0.8× 165 2.4× 39 0.8× 35 791
Yongbing Wu China 14 530 0.9× 343 0.6× 84 0.9× 110 1.6× 36 0.7× 35 710
Chenlong Song China 9 778 1.3× 528 1.0× 84 0.9× 146 2.1× 47 0.9× 11 1.0k
Yeqing Zou China 12 363 0.6× 259 0.5× 88 0.9× 43 0.6× 20 0.4× 18 488
Qiurong Ye China 13 401 0.7× 332 0.6× 64 0.7× 169 2.4× 60 1.2× 20 679
Ping Zhan China 10 271 0.5× 213 0.4× 88 0.9× 97 1.4× 18 0.4× 27 463
Ganxun Li China 12 232 0.4× 170 0.3× 119 1.3× 108 1.5× 29 0.6× 29 421
Xingxiang Xu China 12 322 0.5× 240 0.4× 140 1.5× 107 1.5× 19 0.4× 33 540
Haicheng Tang China 12 274 0.5× 176 0.3× 50 0.5× 60 0.9× 19 0.4× 25 404

Countries citing papers authored by Hiroko Mataki

Since Specialization
Citations

This map shows the geographic impact of Hiroko Mataki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Mataki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Mataki more than expected).

Fields of papers citing papers by Hiroko Mataki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Mataki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Mataki. The network helps show where Hiroko Mataki may publish in the future.

Co-authorship network of co-authors of Hiroko Mataki

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Mataki. A scholar is included among the top collaborators of Hiroko Mataki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Mataki. Hiroko Mataki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mizuno, Keiko, Hiroko Mataki, Takayuki Arai, et al.. (2017). The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes. Journal of Human Genetics. 62(7). 671–678. 64 indexed citations
2.
Kumamoto, Tomohiro, Naohiko Seki, Hiroko Mataki, et al.. (2016). Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma. International Journal of Oncology. 49(5). 1870–1880. 46 indexed citations
3.
Kamikawaji, Kazuto, Naohiko Seki, Masaki Watanabe, et al.. (2016). Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis. Journal of Human Genetics. 61(12). 985–993. 54 indexed citations
4.
Koshizuka, Keiichi, Toyoyuki Hanazawa, Ichiro Fukumoto, et al.. (2016). Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma. Journal of Human Genetics. 62(1). 113–121. 53 indexed citations
5.
Mizuno, Keiko, Hiroko Mataki, Naohiko Seki, et al.. (2016). MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis. Journal of Human Genetics. 62(1). 57–65. 56 indexed citations
6.
Mataki, Hiroko, Naohiko Seki, Keiko Mizuno, et al.. (2016). Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma. Oncotarget. 7(44). 72084–72098. 64 indexed citations
7.
Matsushita, Ryo, Naohiko Seki, Takeshi Chiyomaru, et al.. (2015). Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer. British Journal of Cancer. 113(2). 282–289. 110 indexed citations
8.
Mizuno, Keiko, Naohiko Seki, Hiroko Mataki, et al.. (2015). Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma. International Journal of Oncology. 48(2). 450–460. 57 indexed citations
9.
Mataki, Hiroko, Hideki Enokida, Takeshi Chiyomaru, et al.. (2014). Downregulation of the microRNA-1/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C. Journal of Human Genetics. 60(2). 53–61. 60 indexed citations
10.
Mataki, Hiroko, Naohiko Seki, Takeshi Chiyomaru, et al.. (2014). Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma. International Journal of Oncology. 46(3). 1039–1050. 40 indexed citations
11.
Chiyomaru, Takeshi, Naohiko Seki, Satoru Inoguchi, et al.. (2014). Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer. International Journal of Oncology. 46(2). 487–496. 74 indexed citations
12.
Inoguchi, Satoru, Naohiko Seki, Takeshi Chiyomaru, et al.. (2014). Tumour‐suppressive microRNA‐24‐1 inhibits cancer cell proliferation through targeting FOXM1 in bladder cancer. FEBS Letters. 588(17). 3170–3179. 51 indexed citations
13.
Kashima, Katsuro, Erika Yamashita, Hiroko Mataki, et al.. (2012). Primary Leiomyosarcoma of the Pulmonary Artery: A Case of a 20-Month Survivor after Incomplete Surgical Resection. Internal Medicine. 51(1). 75–78. 3 indexed citations
14.
Mataki, Hiroko, et al.. (2011). [A case of pulmonary toxocariasis successfully treated with ivermectin].. PubMed. 49(5). 399–403. 4 indexed citations
15.
16.
Mataki, Hiroko, Takeshi Inagaki, M. Yokoyama, & Sakan Maeda. (1994). ICAM-1 expression and cellular injury in cultured endothelial cells under hypoxia/reoxygenation.. PubMed. 40(2). 49–63. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu Qi Breakdown of academic impact, for papers by Mohammed Abba Breakdown of academic impact, for papers by Yongbing Wu Breakdown of academic impact, for papers by Chenlong Song Breakdown of academic impact, for papers by Yeqing Zou Breakdown of academic impact, for papers by Qiurong Ye Breakdown of academic impact, for papers by Ping Zhan Breakdown of academic impact, for papers by Ganxun Li Breakdown of academic impact, for papers by Xingxiang Xu Breakdown of academic impact, for papers by Haicheng Tang
Rankless by CCL
2026